Short‐course blood transfusion therapy with hydroxyurea, a functional strategy in the management of stroke in children with sickle cell disease
British Journal of Haematology · 2026-06 · 208 (6) · 2194-2202
DOI: 10.1111/bjh.70399 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 05.04.2026. Verfasst von Edamisan Temiye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, College of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell, Stroke, Blood Transfusion. Die Arbeit nennt 55 Literaturangaben.
Themen: Kinderkrankenpflege, Schlaganfall
Abstract (Originalsprache)
Cerebrovascular accidents are serious complications of sickle cell disease (SCD). Children with abnormal transcranial Doppler (TCD) readings are at higher risk for stroke, and those with prior strokes have increased risk of recurrence. Chronic blood transfusion therapy (BTT) is the standard treatment for stroke prevention; hydroxyurea (hydroxycarbamide [HU]), a recommended alternative, is less effective. This study explores the use of modified short BTT combined with HU for stroke prevention in SCD. We reviewed medical records of 170 children (ages 2–16) with abnormal TCD or prior stroke treated with monthly BTT for 6–8 months and HU. TCD results and stroke incidence were assessed 1 year after discontinuing BTT. Among the children, 136 (80%) had abnormal TCD, 15 (11.2%) had current stroke and 19 (8.8%) had prior stroke. After discontinuation of BTT, abnormal TCD readings decreased significantly to 18.7% and 16.9% ( p < 0.05); those with normal TCD increased significantly from 38.8% to 52.8% ( p < 0.05) after 1 year. TCD velocity decreased significantly during the same period ( p < 0.05). Only 2 (1.5%) children with abnormal TCD experienced stroke. Overall, 13 (7.8%) had stroke by 1‐year post BTT. In conclusion, the combination of short‐course BTT and HU significantly reduced stroke risk and incidence of stroke in children with SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, College of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria.
- East and North HertfordshireTrust, East of England Deanery, Stevenage, UK.
- Department of Paediatrics, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria.
- Department of Haematology & Blood Transfusion, College of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria.
- Nigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.
ORCID-Profile: Edamisan Temiye, Ugonna Fakile, Chibuzor Ogamba
Zitieren
APA
Temiye, E., Akinsete, A., Joacquim, A., Fakile, U., Ashefor, O., Ogamba, C., Ogbenna, A., Adeyemo, N., Okodugha, O., Edokpolo, E., Elemo, O., & Salako, A. (2026). Short‐course blood transfusion therapy with hydroxyurea, a functional strategy in the management of stroke in children with sickle cell disease. British Journal of Haematology, 208(6), 2194-2202. https://doi.org/10.1111/bjh.70399
Vancouver
Temiye E, Akinsete A, Joacquim A, Fakile U, Ashefor O, Ogamba C, et al. Short‐course blood transfusion therapy with hydroxyurea, a functional strategy in the management of stroke in children with sickle cell disease. British Journal of Haematology. 2026;208(6):2194-2202. doi:10.1111/bjh.70399
BibTeX
@article{Temiye2026,
author = {Temiye, Edamisan and Akinsete, Adeseye and Joacquim, Adetokunbo and Fakile, Ugonna and Ashefor, Olivia and Ogamba, Chibuzor and Ogbenna, Ann and Adeyemo, Nimota and Okodugha, Oladunni and Edokpolo, Ehiosu and Elemo, Olaide and Salako, Abideen},
title = {Short‐course blood transfusion therapy with hydroxyurea, a functional strategy in the management of stroke in children with sickle cell disease},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {6},
pages = {2194--2202},
doi = {10.1111/bjh.70399}
}
EUVIMED